Protection against cervical cancer versus decreasing harms from screening - What would U.S. patients and clinicians prefer, and do their preferences matter?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 28279259.
- Also identified by DOI 10.1016/j.ypmed.2016.12.041 and PMC identifier 5536951.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The primary goal for many providers in the United States has been to deliver the level of protection against cervical cancer afforded by annual cervical cytology while improving screening test performance. Adoption of recent screening recommendations has been inconsistent and has created considerable consternation and confusion. This editorial addresses the perspective of U.S. patients and providers and how their preferences may run counter to current screening recommendations.
Medical subject headings
- Attitude of Health Personnel
- Patient Preference
- Uterine Cervical Neoplasms